Caprine Arthritis Encephalitis (CAE - neurological)

Caprine arthritis encephalitis is a chronic viral disease of goats caused by a small ruminant lentivirus closely related to the ovine progressive pneumonia virus (maedi-visna) of sheep. While CAE is perhaps best known for causing progressive arthritis in adult goats, the neurological form of the disease produces devastating encephalomyelitis primarily in young kids, resulting in progressive paralysis and death. The neurological presentation represents a particularly tragic manifestation of this infection, as it typically affects otherwise healthy, thriving kids between two and six months of age.

The CAE virus infects goats worldwide and has been identified in goat populations across North America, Europe, Africa, Asia, and Oceania. Seroprevalence varies dramatically among regions, operations, and breed groups, ranging from less than five percent in some populations to over eighty percent in heavily infected herds. The neurological form of disease occurs sporadically even in infected herds, as most infected goats develop arthritic or pneumonic disease later in life rather than neurological disease in youth. However, when neurological CAE does occur, it produces rapidly progressive, typically fatal disease.

The economic impact of CAE extends beyond mortality losses to include reduced productivity, premature culling, testing and control program costs, and limitations on animal sales and movement. Herds with high CAE prevalence experience reduced milk production, increased veterinary costs, and market limitations for breeding stock sales. The neurological form creates immediate losses of affected kids, while the chronic arthritic form causes ongoing productivity losses throughout infected animals' lives. Welfare concerns center on the suffering of affected animals and the difficult decisions surrounding management of infected herds.

No cure or vaccine exists for CAE, making prevention through biosecurity and testing essential for herd health management. The neurological form carries a grave prognosis, with most affected kids deteriorating to the point where humane euthanasia is necessary. Control programs based on preventing transmission from infected dams to kids have proven effective in reducing herd prevalence, and CAE-free herds command premium prices for breeding stock. Understanding both the neurological and other manifestations of CAE helps goat producers make informed decisions about testing, management, and control strategies.

The primary cause of caprine arthritis encephalitis is infection with the CAE virus, a lentivirus belonging to the same viral family as HIV in humans and other important animal lentiviruses. The CAE virus preferentially infects cells of the monocyte-macrophage lineage, establishing persistent infection that the immune system cannot eliminate. The virus integrates into the host cell genome, creating a lifelong infection that can be transmitted to offspring and herdmates. Different viral strains exist with varying pathogenic properties, which may partially explain why some infected goats develop neurological disease while others develop arthritis or remain clinically normal.

Transmission of CAE virus occurs primarily through ingestion of infected colostrum or milk by newborn kids, making dam-to-kid transmission the dominant route of infection spread within herds. The virus is present in high concentrations in colostrum and milk of infected does, and the newborn kid's intestinal permeability allows viral entry into the bloodstream. This vertical transmission pathway drives herd-level prevalence over time, with infection passing from generation to generation through normal nursing behavior. Kids infected through colostrum often develop the neurological form of disease months later.

Environmental and management factors significantly influence transmission patterns within goat herds. Practices that allow contact between infected and susceptible animals, particularly during the perinatal period, drive infection spread. Co-mingling of kids from infected and uninfected dams allows transmission through social contact and potential milk stealing. Common use of equipment including feeding bottles and nipples between infected and clean groups can transmit virus. Blood contact through tattooing, ear tagging, or veterinary procedures using inadequately sanitized equipment represents another transmission route.

Risk factors for developing the neurological form of CAE specifically, rather than other disease manifestations, are not fully understood but include young age at infection and possible viral strain differences. Kids infected through colostrum in the immediate postnatal period appear more likely to develop neurological disease than those infected later in life. Stress factors including weaning, dietary changes, and concurrent infections may precipitate clinical disease in previously subclinical infections. Immune system development during the first months of life may influence whether infection manifests as neurological disease or remains latent.

The pathophysiology of neurological CAE involves viral invasion of the central nervous system with resulting inflammatory demyelination, particularly affecting the white matter of the brain and spinal cord. The term leukoencephalomyelitis reflects this pattern of white matter inflammation throughout the central nervous system. Viral replication in macrophages within the central nervous system triggers immune-mediated damage to surrounding myelin sheaths, disrupting nerve impulse conduction. The resulting demyelination produces the progressive paralysis characteristic of neurological CAE, with clinical signs reflecting the specific anatomic distribution of lesions.

Early warning signs of neurological CAE in young kids may be subtle and easily attributed to other causes before the characteristic progressive paralysis develops. Initial symptoms often include mild hindlimb weakness, slight ataxia, or changes in gait that might be dismissed as minor injuries or developmental variations. Affected kids may show reluctance to stand or nurse, decreased activity compared to penmates, and subtle balance problems visible during play. Astute observers may notice that affected kids tire more quickly during normal activities or seem slightly uncoordinated compared to healthy cohorts.

Common symptoms of neurological CAE progress over days to weeks from initial subtle changes to obvious paralysis. Hindlimb weakness is typically the predominant clinical feature, progressing from mild ataxia to severe paresis or complete paralysis. Affected kids may develop a characteristic bunny-hopping gait as hindlimb dysfunction worsens, followed by inability to rise on the hindlimbs while maintaining some forelimb function. Proprioceptive deficits cause affected kids to place their feet abnormally and have delayed responses to limb repositioning. Urinary and fecal incontinence may develop as spinal cord function deteriorates.

Behavioral changes in kids with neurological CAE include frustration with inability to keep up with herdmates, isolation from the group due to mobility limitations, and altered nursing behavior related to weakness. Affected kids typically remain bright and alert, maintaining appetite and interest in their surroundings despite progressive physical limitations. This preservation of mentation while physical function deteriorates creates particularly challenging welfare situations, as kids may struggle repeatedly to stand or move without success. Depression or decreased appetite, when present, may indicate concurrent infection or advanced disease.

Physical signs detectable on neurological examination help localize lesions and confirm central nervous system involvement. Hindlimb reflexes may be normal to exaggerated, indicating upper motor neuron disease affecting spinal cord rather than peripheral nerves. Muscle tone is often normal or increased in affected limbs, distinguishing spinal cord disease from lower motor neuron conditions. Crossed extensor reflexes and other indicators of upper motor neuron dysfunction support spinal cord localization. In some cases, head tilt, nystagmus, or circling indicates brain involvement in addition to spinal cord disease.

Symptom progression in neurological CAE typically follows a relentless course of worsening paralysis over days to weeks. Kids that initially show mild hindlimb weakness progress to complete hindlimb paralysis, often followed by forelimb involvement and eventual quadriplegia. Respiratory function may become compromised in severe cases with extensive brainstem or cervical spinal cord involvement. Weight loss occurs as mobility limitations interfere with nursing and feeding behavior. Secondary complications including pressure sores, urine scald, and aspiration pneumonia develop in kids unable to move normally.

Emergency symptoms in neurological CAE include rapid deterioration of motor function, respiratory distress suggesting brainstem involvement, and signs of secondary complications such as pneumonia. Any young goat kid showing progressive weakness or paralysis warrants immediate veterinary evaluation to establish diagnosis and determine prognosis. While neurological CAE is not a medical emergency in the traditional sense of requiring immediate life-saving intervention, prompt evaluation helps families make informed decisions about whether treatment attempts are appropriate or whether humane euthanasia best serves the animal's welfare.

Clinical examination of kids with suspected neurological CAE focuses on localizing neurological deficits and ruling out other causes of paralysis in young goats. The neurological examination assesses mental status, gait, postural reactions, spinal reflexes, and cranial nerve function. The pattern of upper motor neuron paralysis predominantly affecting hindlimbs, combined with the signalment of a young kid and chronic progressive course, strongly suggests neurological CAE. Careful palpation of the spine rules out traumatic injury or vertebral abnormalities that might cause similar signs.

Diagnostic testing for CAE includes serological testing to detect antibodies against the virus, though interpretation requires understanding of test limitations. ELISA and agar gel immunodiffusion (AGID) tests detect antibodies in blood, with ELISA generally offering greater sensitivity. Positive serology confirms infection but does not diagnose the neurological form specifically, as most infected goats never develop neurological disease. Conversely, very young kids or recently infected animals may test negative despite active infection due to insufficient time for antibody development. Cerebrospinal fluid analysis may show elevated protein and mononuclear pleocytosis consistent with viral encephalomyelitis.

Postmortem examination and histopathology provide definitive diagnosis in fatal cases, revealing the characteristic demyelinating lesions throughout the central nervous system white matter. Gross findings may be subtle, but microscopic examination shows periventricular demyelination, mononuclear inflammatory infiltrates, and gliosis. Immunohistochemistry or PCR testing on neural tissues can detect viral antigen or nucleic acid, confirming CAE virus involvement. Necropsy of affected kids provides valuable diagnostic confirmation and can identify any concurrent conditions contributing to clinical disease.

Differential diagnosis for progressive paralysis in young goats includes various infectious, toxic, traumatic, and congenital conditions. Enzootic ataxia from copper deficiency causes posterior ataxia in kids but typically affects multiple animals in copper-deficient herds and may respond to supplementation. Spinal cord trauma produces acute onset paralysis with history of injury. White muscle disease from selenium and vitamin E deficiency causes weakness but typically affects skeletal muscles more prominently than central nervous system function. Listeriosis causes neurological disease but typically includes brainstem signs such as head tilt and facial paralysis. Spinal abscess or vertebral osteomyelitis may cause progressive paralysis but often includes fever and localized pain.

No specific treatment exists for caprine arthritis encephalitis, as no antiviral medications effectively eliminate the lentivirus or halt disease progression. The integrated nature of lentiviral infection, with proviral DNA incorporated into the host cell genome, makes viral elimination impossible with current therapeutic approaches. This fundamental untreatable nature of CAE infection applies to all forms of the disease, including the neurological manifestation in young kids. Treatment therefore focuses entirely on supportive care to maintain comfort and quality of life while the disease runs its course.

Medical management of neurological CAE is limited to supportive measures and symptomatic treatment of secondary complications. Anti-inflammatory medications including corticosteroids have been used in attempts to reduce central nervous system inflammation, though evidence of clinical benefit is limited and immunosuppression may have detrimental effects. Pain management may be appropriate if affected kids show signs of discomfort. Treatment of secondary infections such as pneumonia or urinary tract infection addresses complications but does not affect the underlying viral disease. Nutritional support ensures adequate intake in kids with mobility limitations affecting nursing.

Supportive care for kids with neurological CAE includes nursing management to prevent complications of recumbency and maintain quality of life. Affected kids should be housed on soft, clean bedding changed frequently to prevent pressure sores and urine scald. Assisted standing and position changes help prevent muscle atrophy and complications of prolonged lateral recumbency. Physical therapy including passive range of motion exercises may help maintain limb function in kids with incomplete paralysis. Assisted feeding or bottle feeding ensures adequate nutrition when nursing is impaired by weakness.

Herd management considerations when neurological CAE is diagnosed include testing of remaining herd members, implementation or enhancement of control measures, and decisions regarding infected animals. All adult goats should be tested to determine herd prevalence and identify infected individuals. Control programs to prevent transmission from infected dams to kids should be implemented or strengthened. Decisions about maintaining versus culling infected adults depend on herd goals, prevalence, and economic considerations.

The prognosis for neurological CAE is grave, with most affected kids deteriorating to the point where humane euthanasia is appropriate. The progressive nature of demyelination means that clinical signs continue to worsen despite supportive care efforts. Kids that cannot stand, cannot nurse effectively, or develop significant secondary complications are appropriate candidates for euthanasia. While some individual variation in disease course exists, the overall trajectory in neurological CAE is one of progressive decline rather than recovery.

Treatment decisions for kids with neurological CAE must balance welfare considerations against emotional attachment and desire to provide every possible chance. The grave prognosis means that extended treatment attempts often prolong suffering without reasonable hope of meaningful recovery. Early euthanasia may best serve the animal's welfare when diagnosis is confirmed and significant paralysis is present. Consultation with veterinarians familiar with CAE helps families understand the prognosis and make informed decisions about treatment versus humane euthanasia.

Recovery from neurological CAE is extremely rare, as the disease typically follows a progressive course of worsening paralysis regardless of supportive care measures. The demyelinating nature of the central nervous system lesions produces permanent neurological damage that cannot regenerate in most cases. While occasional anecdotal reports describe kids with mild neurological signs stabilizing or showing limited improvement, these cases likely represent either misdiagnosis or unusually mild disease manifestations. The vast majority of kids with confirmed neurological CAE deteriorate until euthanasia or natural death occurs.

The typical disease course following clinical onset spans days to weeks of progressive deterioration. Kids may initially stabilize briefly with intensive supportive care before resuming decline. Hindlimb paralysis worsens until affected kids cannot stand on their hindlimbs, followed by forelimb involvement in many cases. Secondary complications including pneumonia, pressure sores, and urine scald may accelerate decline. Most affected kids reach a point where humane euthanasia is clearly indicated within one to four weeks of symptom onset, though individual variation in disease progression exists.

Prognosis for kids diagnosed with neurological CAE is uniformly poor. Once clinical signs of paralysis develop, the expected outcome is progressive decline leading to death or euthanasia. Factors that might influence prognosis include the severity of clinical signs at diagnosis, rate of progression, and quality of supportive care, but none of these factors reliably predict recovery. The diagnosis of neurological CAE should prompt serious consideration of humane euthanasia rather than extended treatment attempts that typically prolong suffering.

Long-term outcomes for the rare kids that might stabilize with mild deficits include permanent neurological impairment, chronic shedding of virus, and unsuitability for breeding purposes due to infection status. Such animals would continue to pose transmission risks to susceptible herdmates and offspring. Even if functional recovery occurred, the infected status would remain permanent, requiring ongoing management to prevent transmission. These considerations make aggressive treatment of neurological CAE cases difficult to justify from both individual animal welfare and herd health perspectives.

Prevention of CAE relies entirely on biosecurity and management practices that interrupt virus transmission, as no vaccine exists for this lentiviral infection. The cornerstone of CAE prevention programs is preventing transmission from infected dams to newborn kids by removing kids from infected dams before nursing and feeding only CAE-negative colostrum or heat-treated colostrum. Kids raised on pasteurized milk from birth have dramatically reduced infection rates compared to naturally nursed kids in infected herds. This dam-kid separation protocol has proven highly effective in reducing herd prevalence over time.

Biosecurity measures for CAE prevention address horizontal transmission pathways including blood contact and direct animal contact. Equipment used for blood-drawing procedures including tattooing and ear tagging should be cleaned and disinfected between animals or dedicated needles used. Shared feeding equipment including bottles and nipples should be thoroughly cleaned between uses on different kids. New animals introduced to the herd should be tested and quarantined until negative status is confirmed. Boundaries between CAE-positive and CAE-negative groups should be maintained strictly to prevent direct contact transmission.

Herd testing programs form the foundation of CAE control and prevention efforts. Regular testing identifies infected animals for segregation or culling, monitors program effectiveness over time, and provides documentation for sales of tested stock. Testing should occur at least annually for all adult animals, with testing of kids at six months of age or older when maternal antibodies have waned. Animals should be retested after potential exposure before being moved back into negative groups. Multiple negative tests over time strengthen confidence in negative status.

Management practices supporting CAE prevention include maintaining closed herds when possible, testing and quarantining all new additions regardless of source, and implementing strict protocols for kid-raising that prevent exposure to infected colostrum or milk. Herds pursuing CAE eradication may choose to cull all positive animals, retain positives in separate groups, or gradually reduce prevalence through selective culling and careful kid management. The appropriate strategy depends on herd prevalence, owner goals, and economic considerations.

Colostrum management for CAE prevention requires either sourcing colostrum from confirmed CAE-negative does or heat-treating colostrum to inactivate virus while preserving immunoglobulin function. Heat treatment at 56 degrees Celsius for 60 minutes effectively inactivates CAE virus while maintaining adequate antibody levels for passive transfer. Commercial colostrum replacers provide another option for herds without access to negative colostrum. Whatever colostrum source is used, kids must receive adequate amounts promptly after birth to ensure successful passive transfer of immunity against other infectious diseases.

Daily management for CAE prevention requires consistent attention to protocols that separate infected and susceptible animals. Kids from positive dams must be removed immediately at birth before any nursing opportunity, requiring observer presence during kidding or bottle-feeding of all newborns as a precaution. Colostrum and milk feeding must follow established protocols to ensure CAE-negative sources reach susceptible kids. Daily observation of all animals monitors for early signs of clinical disease that might prompt testing or management changes.

Housing and environmental management support CAE control through separation of infected and negative animals and prevention of direct contact transmission. Physical separation between groups prevents contact transmission that can occur through respiratory secretions, wounds, or other routes. Kidding facilities should be designed to allow immediate removal of newborns from dams. Feeding equipment, waterers, and other shared items should be managed to prevent cross-contamination between groups. Ventilation and stocking density considerations may influence transmission rates in housed groups.

Herd health programs for goat operations should incorporate CAE testing and control as fundamental components. Annual testing of all adult animals tracks herd status and identifies any new infections requiring management changes. Integration of CAE protocols with other herd health activities including vaccination, deworming, and reproductive management improves efficiency and compliance. Veterinary involvement in program design and monitoring helps ensure protocols are appropriate and effective. Regular review of program results guides adjustments to control strategies.

Record keeping for CAE management documents test results, kidding records linking kids to dams, colostrum and milk sources for each kid, and disease occurrences. Complete records enable traceback if infections occur in supposedly negative kids, identifying protocol failures for correction. Testing records provide documentation for breeding stock sales and support certification programs in some areas. Electronic record systems facilitate data analysis and trend monitoring over time.

Economic considerations for CAE management include testing costs, facility modifications for group separation, increased labor for protocol implementation, and value differences between CAE-negative and positive animals. Investment in CAE control programs typically returns value through premium prices for certified breeding stock, reduced disease losses, improved production in clean herds, and expanded marketing opportunities. The appropriate level of investment depends on operation type, with herds selling breeding stock benefiting most from rigorous programs while commercial meat goat operations may implement less intensive measures.

All goat breeds are susceptible to CAE virus infection, though reported seroprevalence varies among breed groups for reasons related primarily to management practices and testing frequency rather than true genetic differences in susceptibility. Dairy goat breeds including Saanen, Alpine, Toggenburg, LaMancha, and Nubian often show higher seroprevalence rates than meat and fiber breeds, reflecting the intensive management and frequent testing that characterizes dairy goat operations. The CAE virus does not discriminate based on genetics, and any breed exposed to infected animals or contaminated colostrum can become infected.

Production type influences CAE prevalence and management approaches significantly. Dairy goat operations with intensive management, show participation, and active breeding stock sales have both higher testing rates and often higher prevalence due to historical movement of infected animals through sales and shows. Meat goat operations with extensive management may have lower prevalence but also less testing, making true status uncertain. Fiber goat operations vary widely in management intensity and CAE status. The increased testing in dairy operations has contributed to more aggressive control programs and availability of CAE-negative genetics in dairy breeds.

Genetic factors influencing susceptibility to CAE virus infection have been investigated, though no practical genetic testing or selection program exists for CAE resistance in goats. Research has identified associations between certain genetic markers and relative susceptibility, but these findings have not translated into applicable breeding strategies. The focus for CAE control remains on preventing viral exposure rather than selecting for genetic resistance. Breeding program decisions should prioritize overall health, production traits, and conformance to breed standards while implementing management protocols to prevent CAE transmission regardless of genetic background.

The arthritic form of CAE is the most common clinical manifestation of CAE virus infection and frequently co-occurs or precedes neurological disease in affected herds. Chronic progressive arthritis primarily affects the carpal joints, causing joint swelling, pain, and progressive lameness in adult goats typically two years of age or older. Some goats develop both arthritic and neurological manifestations, while others show only one disease form or remain clinically normal despite infection. Understanding that the same virus causes both conditions helps inform herd-level control decisions.

Other disease manifestations of CAE virus infection include indurative mastitis (hard udder syndrome) and chronic interstitial pneumonia. The mastitis form causes progressive fibrosis of the udder, reducing milk production and creating a firm, non-functional udder. The pneumonic form produces chronic respiratory disease similar to ovine progressive pneumonia in sheep. These conditions share the characteristic lentiviral pathology of chronic inflammation leading to tissue damage and organ dysfunction. Individual infected goats may develop any combination of clinical manifestations over their lifetime.

Conditions with similar clinical presentation to neurological CAE include various other causes of progressive paralysis in young goats. Copper deficiency causing enzootic ataxia produces posterior ataxia but typically affects multiple kids in deficient herds and may respond to supplementation. Spinal trauma causes acute paralysis with history of injury rather than progressive onset. Listeriosis produces neurological disease but typically includes brainstem signs. Toxoplasmosis can cause neurological disease in kids but occurs sporadically and often includes other organ involvement. Spinal abscess causes progressive paralysis but often includes fever and localized pain along the spine.